TNGX — Tango Therapeutics, Inc. stock price, charts and financials

QT64Tango Therapeutics, Inc.

Tango Therapeutics, Inc. (NASDAQ: TNGX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
29.36
+2.15+7.90%
OverviewShort InterestFilings
TNGXQT64Tango Therapeutics, Inc.·NASDAQ
29.36+7.90%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 02, 20264Statement of changes in beneficial ownership
Jun 23, 20268-KCurrent report
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20263Initial statement of beneficial ownership
Jun 10, 2026FWPFree writing prospectus
Jun 10, 2026424B5Prospectus
Jun 10, 20268-KCurrent report
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20268-KCurrent report
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 2026424B5Prospectus
Jun 08, 20264Statement of changes in beneficial ownership
Jun 04, 20268-KCurrent report
Jun 03, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 202610-QQuarterly report
May 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 20268-KCurrent report
May 11, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 08, 20268-KCurrent report
May 06, 2026SC 13GBeneficial ownership statement (passive)
#1 / 25 of 322
Page
▼
/ 13